Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: mistake (35), fault (22), slip (31)

CytarabineSC

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE SC Regimen • Acute Myeloid Leukaemia – Cytarabine SC Indication • Acute myeloid leukaemia in those 60 years
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/CytarabineSC.pdf

Cytarabine3000

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (3000mg/m2) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (3000mg/m2) Indication • Consolidation
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine3000.pdf

AmsacrineCytarabineEtoposide_MACE

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AMSACRINE-CYTARABINE-ETOPOSIDE In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Amsacrine-Cytarabine-Etoposide (MACE) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmsacrineCytarabineEtoposide-MACE.pdf

Topotecan (1,8,15)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8, 15) Regimen Ovary – Topotecan (1, 8, 15) Indication Second-line or subsequent treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan1815.pdf

Topotecan (1,8)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 8) Regimen Ovary – Topotecan (1, 8) Indication Second-line or subsequent treatment of platinum
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan18.pdf

Topotecan (1,2,3,4,5)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER TOPOTECAN INTRAVENOUS (1, 2, 3, 4, 5) Regimen Ovary – Topotecan (1, 2, 3, 4, 5) Indication Second
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Topotecan12345.pdf

Gemcitabine ver1

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER GEMCITABINE Regimen Ovarian – Gemcitabine Indication The treatment of advanced ovarian cancer WHO Performance status 0, 1, 2
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Gemcitabine-ver1.pdf

Etoposide PO

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER ETOPOSIDE ORAL Regimen Ovary-Etoposide Oral Indication Second line or subsequent treatment of recurrent platinum resistant ovarian
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/EtoposidePO.pdf

Cyclophosphamide PO

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CYCLOPHOSPHAMIDE ORAL Regimen Ovary – Cyclophosphamide Oral Indication Relapsed/refractory ovarian cancer in patients unsuitable for other treatments
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CyclophosphamidePO.pdf

Raltitrexed Ver 1.2

Description: Chemotherapy Protocol COLORECTAL CANCER Regimen RALTITREXED Colorectal Cancer– Raltitrexed Indication Treatment of metastatic / advanced colorectal cancer where fluorouracil and / or capecitabine
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/RaltitrexedVer12.pdf

101 to 110 of 630

Previous … 9 10 11 12 13 … Next